Cited by 163Advanced Glycation End Products researchChronic Kidney Disease and DiabetesNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor

Open access

Cai, Weijing, He, John C., Zhu, Li, Lu, Changyong, Vlassara, Helen·2006·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0600362103PMC PMC1564251

Open this paper in CoChat — free account

Abstract

Advanced glycation end product receptors (AGERs) play distinct functional roles in both the toxicity and disposal of advanced glycation end products (AGEs), substances that are linked to diabetes and aging. Overexpression of AGER1 in murine mesangial cells (MCs) (MC-R1) inhibited AGE-induced MAPK1,2 phosphorylation and NF-kappaB activity and also increased AGE degradation. The mechanism of the inhibitory effects of AGER1, upstream of MAPK, was explored in MCs and HEK293 AGER1-expressing cells. AGE-induced Ras activation was found to be linked to Shc/Grb2 complex formation and Shc phosphorylation in MCs, responses that were markedly reduced in MC-R1 cells. AGE responses also included EGF receptor (EGFR) phosphorylation in MCs or HEK293 cells, but this link was blocked in both MC-R1 and HEK293-R1 cells. Coexpression of AGER1 and EGFR in HEK293 cells decreased AGE-mediated EGFR and p44/p42 phosphorylation but not EGF-induced p44/p42 activation. AGE, S100/calgranulin, or H(2)O(2) promoted MAPK phosphorylation in EGFR(+) cells in a manner that was inhibitable by an EGFR inhibitor, AG1478. Also, in AGER1 cells, AGE-induced H(2)O(2) formation and AGE- or S100-induced p44/p42 phosphorylation were suppressed, and these effects were restored by R1 siRNA. These data confirm that R1 negatively regulates AGE-mediated oxidant stress-dependent signaling via the EGFR and Shc/Grb2/Ras pathway. AGER1 could serve as a model for developing therapeutic targets against vascular and kidney disorders related to diabetes and aging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0600362103

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., & Finkel, T. (1995) · Science · doi:10.1126/science.270.5234.296 · Cited by 2,520
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,256
Signal transduction via the MAP kinases: proceed at your own RSK.
Blenis, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5889 · Cited by 1,233
Oxygen radicals and signaling
Finkel, T. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80147-6 · Cited by 1,170
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,088
Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 723
Epidermal growth factor receptors: critical mediators of multiple receptor pathways
Hackel, P. O., Zwick, E., Prenzel, N., & Ullrich, A. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80024-6 · Cited by 604

Show all 40 references

Research works printed but not linked: 2

T Basu, PH Warne, J Dounward Oncogene 9, 3483–3534 (1994).
10.1074/jbc.272.28.17810 · DOI · Paper page

Sorted by citations

Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Advanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
Vlassara, H., & Uribarri, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0453-1 · Cited by 594
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
Coughlan, M. T., Thorburn, D. R., Penfold, S. A., Laskowski, A., Harcourt, B. E., Sourris, K. C., Tan, A. L. Y., Fukami, K., Thallas‐Bonke, V., Nawroth, P. P., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050514 · Cited by 471
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 469
Hyperglycemia and Glycation in Diabetic Complications
Nègre‐Salvayre, A., Salvayre, R., Augè, N., Pamplona, R., & Portero‐Otín, M. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2484 · Cited by 426
Dietary Advanced Glycation End Products and Their Role in Health and Disease
Uribarri, J., del Castillo, M. D., de la Maza, M. P., Filip, R., Gugliucci, A., Luévano‐Contreras, C., Macías-Cervantes, M. H., Bastos, D. H. M., Medrano, A., Menini, T., et al. (2015) · Advances in Nutrition · doi:10.3945/an.115.008433 · Cited by 381
Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease
Chen, J., Zeng, F., Forrester, S. J., Eguchi, S., Zhang, M., & Harris, R. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00030.2015 · Cited by 336
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1
Cai, W., Ramdas, M., Zhu, L., Chen, X., Striker, G. E., & Vlassara, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205847109 · Cited by 337
Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes
Uribarri, J., Cai, W., Ramdas, M., Goodman, S., Pyzik, R., Chen, X., Zhu, L., Striker, G. E., & Vlassara, H. (2011) · Diabetes Care · doi:10.2337/dc11-0091 · Cited by 320
Self-citation
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes
Yamagishi, S. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.007 · Cited by 312
Dangers Within
Rosin, D. L., & Okusa, M. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040430 · Cited by 292
AGE restriction in diabetes mellitus: a paradigm shift
Vlassara, H., & Striker, G. E. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.74 · Cited by 277
Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
Bhattacharjee, N., Barma, S., Konwar, N., Dewanjee, S., & Manna, P. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.022 · Cited by 273
Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review
Zhou, M., Zhang, Y., Shi, L., Li, L., Zhang, D., Gong, Z., & Wu, Q. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107282 · Cited by 286
Advanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 228
Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1
Vlassara, H., Cai, W., Goodman, S., Pyzik, R., Yong, A., Chen, X., Zhu, L., Neade, T., Beeri, M. S., Silverman, J. M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0089 · Cited by 227
Acute Kidney Injury in Older Adults
Anderson, S., Eldadah, B. A., Halter, J. B., Hazzard, W. R., Himmelfarb, J., Horne, F. M., Kimmel, P. L., Molitoris, B. A., Murthy, M., O’Hare, A. M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090934 · Cited by 217
Advanced glycoxidation products and impaired diabetic wound healing
Peppa, Μ., Stavroulakis, P., & Raptis, S. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00518.x · Cited by 220
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Ahmad, S., Khan, H., Siddiqui, Z., Khan, M. Y., Rehman, S., Shahab, U., Godovikova, T. S., Silnikov, V. N., & Moinuddin, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.001 · Cited by 196
Epidermal growth factor receptor is a preferred target for treating Amyloid-β–induced memory loss
Wang, L., Chiang, H.-C., Wu, W., Liang, B., Xie, Z., Yao, X., Ma, W., Du, S., & Zhong, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208011109 · Cited by 190
Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells
Kuntz, S., Rudloff, S., & Kunz, C. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507824068 · Cited by 186
Oral Glycotoxins Determine the Effects of Calorie Restriction on Oxidant Stress, Age-Related Diseases, and Lifespan
Cai, W., He, C., Zhu, L., Xue, C., Zheng, F., Striker, G. E., & Vlassara, H. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080152 · Cited by 188
Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease
Ruiz, H. H., Ramasamy, R., & Schmidt, A. M. (2019) · Endocrinology · doi:10.1210/endocr/bqz006 · Cited by 186
Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
Funk, S. D., Yurdagul, A., & Orr, A. W. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/569654 · Cited by 176
Reduced Oxidant Stress and Extended Lifespan in Mice Exposed to a Low Glycotoxin Diet
Cai, W., He, C., Zhu, L., Chen, X., Wallenstein, S. R., Striker, G. E., & Vlassara, H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061281 · Cited by 177
Ursolic Acid Attenuates D-Galactose-Induced Inflammatory Response in Mouse Prefrontal Cortex through Inhibiting AGEs/RAGE/NF- B Pathway Activation
Lu, J. L., Wu, D.-M., Zheng, Y., Hu, B., Zhang, Z.-F., Ye, Q., Liu, C., Shan, Q., & Wang, Y.-J. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq002 · Cited by 174
Advanced Glycation Endproducts in Diabetes and Diabetic Complications
Vlassara, H., & Striker, G. E. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.005 · Cited by 171
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
González, N., Prieto, I., del Puerto‐Nevado, L., Portal‐Núñez, S., Ardura, J. A., Cortón, M., Fernández‐Fernández, B., Aguilera, Ó., Gómez‐Guerrero, C., Mas, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14472 · Cited by 177
Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging
Vlassara, H., Torreggiani, M., Post, J. B., Zheng, F., Uribarri, J., & Striker, G. E. (2009) · Kidney International · doi:10.1038/ki.2009.401 · Cited by 161
Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor
Chuang, P. Y., Yu, Q., Fang, W., Uribarri, J., & He, J. C. (2007) · Kidney International · doi:10.1038/sj.ki.5002456 · Cited by 152
Effect of diet-derived advanced glycation end products on inflammation
Kellow, N. J., & Coughlan, M. T. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv030 · Cited by 160
A Role for Advanced Glycation End Products in Molecular Ageing
Zgutka, K., Tkacz, M., Tomasiak, P., & Tarnowski, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129881 · Cited by 158
Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology
Nedić, O., Rattan, S. I. S., Grune, T., & Trougakos, I. P. (2013) · Free Radical Research · doi:10.3109/10715762.2013.806798 · Cited by 162
Alteration of Forkhead Box O (Foxo4) Acetylation Mediates Apoptosis of Podocytes in Diabetes Mellitus
Chuang, P. Y., Dai, Y., Liu, R., He, H., Kretzler, M., Jim, B., Cohen, C. D., & He, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023566 · Cited by 144
Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease
Vlassara, H., Uribarri, J., Cai, W., Goodman, S., Pyzik, R., Post, J. B., Grosjean, F., Woodward, M., & Striker, G. E. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12891211 · Cited by 143
Metabolism addiction in pancreatic cancer
Blum, R., & Kloog, Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.38 · Cited by 138
Effect of advanced glycation end product intake on inflammation and aging: a systematic review
Puyvelde, K. V., Mets, T. F., Njemini, R., Beyer, I., & Bautmans, I. (2014) · Nutrition Reviews · doi:10.1111/nure.12141 · Cited by 128
Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection
Reddy, N. M., Kleeberger, S. R., Yamamoto, M. P., Kensler, T. W., Scollick, C., Biswal, S. S., & Reddy, S. P. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00126.2007 · Cited by 113
AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation
Cai, W., He, C., Zhu, L., Chen, X., Striker, G. E., & Vlassara, H. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00350.2007 · Cited by 107
AGE–RAGE Stress, Stressors, and Antistressors in Health and Disease
Mishra, M., & Prasad, K. (2017) · International Journal of Angiology · doi:10.1055/s-0037-1613678 · Cited by 111
Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice
Belmadani, S., Palen, D. I., González-Villalobos, R. A., Boulares, H. A., & Matrougui, K. (2008) · Diabetes · doi:10.2337/db07-0739 · Cited by 106
Chronic administration of troxerutin protects mouse brain against d-galactose-induced impairment of cholinergic system
Lu, J. L., Wu, D., Hu, B., Cheng, W. P., Zheng, Y., Zhang, Z.-F., Ye, Q., Fan, S., Shan, Q., & Wang, Y. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.09.006 · Cited by 102
Lipid glycation and protein glycation in diabetes and atherosclerosis
Miyazawa, T., Nakagawa, K., Shimasaki, S., & Nagai, R. (2010) · Amino Acids · doi:10.1007/s00726-010-0772-3 · Cited by 99
Glycoxidative Stress and Cardiovascular Complications in Experimentally-Induced Diabetes: Effects of Antioxidant Treatment
Karasu, Ç. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010240 · Cited by 99
Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance
Ottum, M. S., & Mistry, A. M. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-3 · Cited by 101
The Danger Signal S100B Integrates Pathogen– and Danger–Sensing Pathways to Restrain Inflammation
Sorci, G., Giovannini, G., Riuzzi, F., Bonifazi, P., Zelante, T., Zagarella, S., Bistoni, F., Donato, R., & Romani, L. R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001315 · Cited by 100
Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression
Júnior, D. A. C. P., da Silva, K. S., Michalani, M. L. E., Yonamine, C. Y., Esteves, J. V. D. C., Fabre, N., Thieme, K., Catanozi, S., Okamoto, M. M., Seraphim, P. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26482-6 · Cited by 94
Aging and glycoxidant stress
Peppa, Μ., Uribarri, J., & Vlassara, H. (2008) · HORMONES · doi:10.1007/bf03401503 · Cited by 83
The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in type 2 diabetes mellitus
Ray, A., Huisman, M. V., Tamsma, J. T., van Asten, J., Bingen, B. O., Broeders, E. A. B. J., Hoogeveen, E. S., van Hout, F. M. A., Kwee, V. A., Laman, B., et al. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.07.008 · Cited by 80
Chronic administration of troxerutin protects mouse kidney against d-galactose-induced oxidative DNA damage
Liu, C., Ma, J., & Lou, Y. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.07.011 · Cited by 79
AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-δ: implications for vascular disease
Cai, W., Torreggiani, M., Zhu, L., Chen, X., He, C., Striker, G. E., & Vlassara, H. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00463.2009 · Cited by 79
Advanced Glycation End Product Homeostasis
Vlassara, H., Uribarri, J., Cai, W., & Striker, G. E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.055 · Cited by 76
Advanced glycation end product accumulation
Mallipattu, S. K., & Uribarri, J. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000062 · Cited by 75
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice
Mastrocola, R., Nigro, D., Chiazza, F., Medana, C., Bello, F. D., Boccuzzi, G., Collino, M., & Aragno, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.022 · Cited by 76
Role of epidermal growth factor receptor in vascular structure and function
Schreier, B., Gekle, M., & Großmann, C. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000441152.62943.29 · Cited by 71
Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer
Jiao, L., Taylor, P. R., Weinstein, S. J., Graubard, B. I., Virtamo, J. R. K., Albanes, D., & Stolzenberg‐Solomon, R. Z. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0066 · Cited by 71
Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway
Humtsoe, J. O., & Kramer, R. H. (2009) · Oncogene · doi:10.1038/onc.2009.419 · Cited by 69
Advanced glycation end products strongly activate platelets
Gawlowski, T., Stratmann, B., Ruetter, R., Bünting, C. E., Menart, B., Weiß, J., Vlassara, H., Koschinsky, T., & Tschoepe, D. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0038-6 · Cited by 67
Receptor for Advanced Glycation End Products Facilitates Host Defense duringEscherichia coli–Induced Abdominal Sepsis in Mice
van Zoelen, M. A. D., Schmidt, A., Florquin, S., Meijers, J. C. M., de Beer, R., de Vos, A. F., Nawroth, P. P., Bierhaus, A., & van der Poll, T. (2009) · The Journal of Infectious Diseases · doi:10.1086/604730 · Cited by 65
Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis
Trougakos, I. P., Sesti, F., Tsakiri, E. N., & Gorgoulis, V. G. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.02.024 · Cited by 63
Advanced Glycation End Product Receptor-1 Transgenic Mice Are Resistant to Inflammation, Oxidative Stress, and Post-Injury Intimal Hyperplasia
Torreggiani, M., Liu, H., Wu, J. C., Zheng, F., Cai, W., Striker, G. E., & Vlassara, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090138 · Cited by 62
Superoxide Destabilization of β-Catenin Augments Apoptosis of High-Glucose-Stressed Mesangial Cells
Lin, C., Wang, J., Ko, J., Surendran, K., Huang, Y., Kuo, Y.-H., & Wang, F. (2008) · Endocrinology · doi:10.1210/en.2007-1372 · Cited by 49
Advanced Glycation End-Products and Their Receptors: Related Pathologies, Recent Therapeutic Strategies, and a Potential Model for Future Neurodegeneration Studies
Pinkas, A., & Aschner, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00034 · Cited by 45
Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: Involvement of advanced glycosylated end products
Remor, A. P., Matos, F., Ghisoni, K., da Silva, T. L., Eidt, G., Burigo, M. O., Bem, A. F. D., Silveira, P. C. L., de León, A., Sanchez, M. C., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.017 · Cited by 48
Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
Nenna, A., Spadaccio, C., Lusini, M., Ulianich, L., Chello, M., & Nappi, F. (2016) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/1574890110666151104120039 · Cited by 43
Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease
Pinto, R. D. S., Minanni, C. A., Lira, A. L. D. A., & Passarelli, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052404 · Cited by 44
Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
Sheng, L., Bayliss, G. P., & Zhuang, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598910 · Cited by 42
Fucoidan–Fucoxanthin Ameliorated Cardiac Function via IRS1/GRB2/ SOS1, GSK3β/CREB Pathways and Metabolic Pathways in Senescent Mice
Chang, P.-M., Li, K.-L., & Lin, Y. (2019) · Marine Drugs · doi:10.3390/md17010069 · Cited by 41
Matrix regeneration proteins in the hypoxia-triggered exosomes of shoulder tenocytes and adipose-derived mesenchymal stem cells
Thankam, F. G., Chandra, I., Diaz, C., Dilisio, M. F., Fleegel, J. P., Gross, R. M., & Agrawal, D. K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03669-7 · Cited by 41
The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs
Nagai, R., Mera, K., Nakajou, K., Fujiwara, Y., Iwao, Y., Imai, H., Murata, T., & Otagiri, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.09.001 · Cited by 39
Methods to investigate advanced glycation end-product and their application in clinical practice
Corica, D., Pepe, G., Currò, M., Aversa, T., Tropeano, A., Ientile, R., & Wasniewska, M. G. (2021) · Methods · doi:10.1016/j.ymeth.2021.12.008 · Cited by 38
The Tyrosine Kinase c-Src Enhances RIG-I (Retinoic Acid-inducible Gene I)-elicited Antiviral Signaling
Johnsen, I. B., Nguyen, T. T., Bergstrøm, B., Fitzgerald, K. A., & Anthonsen, M. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808233200 · Cited by 36
Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract
van der Lugt, T., Opperhuizen, A., Bast, A., & Vrolijk, M. F. (2020) · Nutrients · doi:10.3390/nu12092814 · Cited by 36
Advanced glycation end‐products activate extracellular signal‐regulated kinase via the oxidative stress‐EGF receptor pathway in renal fibroblasts
Chen, S., Guh, J., Hwang, C., Chiou, S.-J., Lin, T., Ko, Y., Huang, J., Yang, Y., & Chuang, L. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22376 · Cited by 34
Endothelial dysfunction in cardiovascular diseases: mechanisms and in vitro models
Grego, A., Fernandes, C., Fonseca, I., Dias‐Neto, M., Costa, R., Leite-Moreira, A. F., Oliveira, S. M., Trindade, F., & Nogueira‐Ferreira, R. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05289-w · Cited by 41
Role of Advanced Glycation Endproducts and Potential Therapeutic Interventions in Dialysis Patients
Mallipattu, S. K., He, C., & Uribarri, J. (2012) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2012.01081.x · Cited by 33
Diet and Obesity-Induced Methylglyoxal Production and Links to Metabolic Disease
Hernandez-Castillo, C., & Shuck, S. C. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00221 · Cited by 35
Prognostic Potential and Tumor Growth-Inhibiting Effect of Plasma Advanced Glycation End Products in Non-Small Cell Lung Carcinoma
Bartling, B., Hofmann, H.-S., Sohst, A., Hatzky, Y., Somoza, V., Silber, R., & Simm, A. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00085 · Cited by 33
Plasma Advanced Glycation End Products (AGEs), Receptors for AGEs and Their Correlation with Inflammatory Markers in Middle School-Age Children
Accacha, S. D., Rosenfeld, W., Jacobson, A., Michel, L., Schnurr, F. J., Shelov, S. P., Ten, S., Boucher‐Berry, C., Carey, D. E., Speiser, P., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000354831 · Cited by 32
AGER1 deficiency-triggered ferroptosis drives fibrosis progression in nonalcoholic steatohepatitis with type 2 diabetes mellitus
Gong, Y., Liu, Z., Zhang, Y., Zhang, J., Yin, Z., & Wu, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01477-z · Cited by 32
Autophagy in Pancreatic Cancer
Grasso, D., Garcia, M. N., & Iovanna, J. (2012) · International Journal of Cell Biology · doi:10.1155/2012/760498 · Cited by 30
Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants
Kovacic, P., & Somanathan, R. (2011) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2011.607171 · Cited by 26
Global upregulation of gene expression associated with renal dysfunction in DOCA–salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: A microarray analysis
Benter, I. F., Canatan, H., Benboubetra, M., Yousif, M. H. M., & Akhtar, S. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.04.004 · Cited by 26
Complications of type 1 diabetes: new molecular findings
Stirban, A. O., Rosen, P., & Tschoepe, D. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20057 · Cited by 26
Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
Zhuang, A., & Forbes, J. M. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9693-z · Cited by 27
Advanced Glycation End Products and Their Involvement in Cardiovascular Disease
Yubero‐Serrano, E. M., & Pérez-Martínez, P. (2020) · Angiology · doi:10.1177/0003319720916301 · Cited by 27
Have we reached the limits for the treatment of diabetic nephropathy?
Hajhosseiny, R., Khavandi, K., Jivraj, N. K., Mashayekhi, S., Goldsmith, D. J. A., & Malik, R. A. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.892580 · Cited by 25
AGE–RAGE Stress in the Pathophysiology of Pulmonary Hypertension and its Treatment
Prasad, K. (2019) · International Journal of Angiology · doi:10.1055/s-0039-1687818 · Cited by 26
Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy
Sourris, K. C., Harcourt, B. E., Penfold, S. A., Yap, F. Y. T., Morley, A. L., Morgan, P. E., Davies, M. J., Baker, S. T., Jerums, G., & Forbes, J. M. (2010) · Experimental Diabetes Research · doi:10.1155/2010/974681 · Cited by 23
Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in KrasG12D/+ mice
Menini, S., Iacobini, C., de Latouliere, L., Manni, I., Vitale, M., Pilozzi, E., Pesce, C. M., Cappello, P., Novelli, F., Piaggio, G., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01665-0 · Cited by 24
Low advanced Glycation end product diet improves the central obesity, insulin resistance and inflammatory profiles in Iranian patients with metabolic syndrome: a randomized clinical trial
Goudarzi, R., Sedaghat, M., Hedayati, M., Hekmatdoost, A., & Sohrab, G. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00614-0 · Cited by 27
Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes
Yap, F. Y. T., Kantharidis, P., Coughlan, M. T., Slattery, R. M., & Forbes, J. M. (2012) · Current Drug Targets · doi:10.2174/138945012799499758 · Cited by 22
Preserving Brain Function in Aging: The Anti-glycative Potential of Berry Fruit
Thangthaeng, N., Poulose, S. M., Miller, M. G., & Shukitt‐Hale, B. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8400-3 · Cited by 22
The role of AGEs in muscle ageing and sarcopenia
Guo, Z.-J., Li, H., Jiang, S., Rahmati, M., Su, J., Yang, S., Wu, Y., Li, Y., & Deng, Z. (2025) · Bone and Joint Research · doi:10.1302/2046-3758.143.bjr-2024-0252.r1 · Cited by 21
N-acetylcysteine Counteracts Adipose Tissue Macrophage Infiltration and Insulin Resistance Elicited by Advanced Glycated Albumin in Healthy Rats
da Silva, K. S., Pinto, P. R., Fabre, N., Gomes, D. J., Thieme, K., Okuda, L. S., Iborra, R. T., Freitas, V. G., Shimizu, M. H. M., Teodoro, W. R., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00723 · Cited by 21
Role of Dietary Advanced Glycation End Products in Diabetes Mellitus
Luévano‐Contreras, C., Garay‐Sevilla, M. E., & Chapman‐Novakofski, K. (2012) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587212460054 · Cited by 22
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial
Gutierrez-Mariscal, F. M., Podadera-Herreros, A., Alcala-Diaz, J. F., Cardelo, M. P., Larriva, A. P. A.-D., de la Cruz, S., Torres-Peña, J. D., Luque, R. M., Pérez‐Martínez, P., Delgado‐Lista, J., et al. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101503 · Cited by 21
Dissection of metabolic pathways in the Db/Db mouse model by integrative proteome and acetylome analysis
Hölper, S., Nolte, H., Bober, E., Braun, T. W., & Krüger, M. (2014) · Molecular BioSystems · doi:10.1039/c4mb00490f · Cited by 19

Authors: Cai, W., He, J. C., Zhu, L., Lu, C., & Vlassara, H.
Affiliations: Icahn School of Medicine at Mount Sinai (US)
Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029
*Division of Experimental Diabetes and Aging, Brookdale Department of Geriatrics, and
Corresponding author: Vlassara, Helen
ORCID: Zhu, Li
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2006-09-12
Volume: 103
Issue: 37
Pages: 13801-13806
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0600362103
PMC: PMC1564251
OpenAlex: W2092612186
Cited by: 163
References: 40
Citations by year: 2026: 2 · 2025: 7 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 14 · 2019: 6 · 2018: 3 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 8 · 2013: 11 · 2012: 9
FWCI: 7.06
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
U.S. Public Health Service (NHL73417)
National Institute on Aging (AG09453, R01AG009453)
National Heart, Lung, and Blood Institute (R01HL073417)
National Institute of Diabetes and Digestive and Kidney Diseases (K08DK065495, DK-65495)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: advanced glycation end products, EGF receptor, MAPK phosphorylation, NF-κB, oxidative stress, hydrogen peroxide, S100/calgranulins, mesangial cells, diabetes mellitus, aging
MeSH terms: Receptor for Advanced Glycation End Products, Src Homology 2 Domain-Containing, Transforming Protein 1, Animals, Cells, Cultured, Epidermal Growth Factor, Humans, Hydrogen Peroxide, Receptors, Immunologic, Transcriptional Activation, Down-Regulation, Oxidants, Glycation End Products, Advanced, Reactive Oxygen Species, Oxidative Stress, ras Proteins, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinase 3, Adaptor Proteins, Signal Transducing, Mesangial Cells, Mice, GRB2 Adaptor Protein, Shc Signaling Adaptor Proteins, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks